Researchers develop technology for real-time monitoring of Parkinson's treatments
Sungkyunkwan University researchers have developed a biochip technology that enables real-time monitoring of Parkinson’s disease treatment responses. The university said Tuesday that the “organoid-on-a-chip” technology combines stem cell-derived “mini-brains” with a nanoplasmonic sensor that maximizes light-matter interactions, enabling real-time monitoring of treatment responses. The findings…
Researchers at Sungkyunkwan University have created a groundbreaking biochip technology for real-time monitoring of Parkinson's disease treatments. The innovative "organoid-on-a-chip" system integrates stem cell-derived mini-brains with a nanoplasmonic sensor that enhances light-matter interactions, allowing for real-time assessment of treatment responses.
The research, published in ACS Nano, involved two university-led teams, each headed by professors Kim In-ki and Park Jong-chan. First authors of the study were Ph.D. candidates Cho Han-jun, Kim Young-jun, and master's candidate Yoon Na-hyun. Professor Kim emphasized the significance of the study, stating that it paves the way for ongoing monitoring of drug effects in living human tissue over time using a highly precise optical sensor.
Moving forward, the team plans to refine the technology into a crucial platform for patient-specific drug development and disease treatment.
Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
